Abstract:The evaluation of inhalation toxicity, drug safety and efficacy assessment, as well as the investigation of complex disease pathomechanisms, are increasingly relying on in vitro lung models. This is due to the progressive shift towards human-based systems for more predictive and translational research. While several cellular models are currently available for the upper airways, modelling the distal alveolar region poses several constraints that make the standardization of reliable alveolar in vitro models relatively difficult. In this work, we present a new and reproducible alveolar in vitro model, that combines a human derived immortalized alveolar epithelial cell line ( AX iAEC) and organ-on-chip technology mimicking the lung alveolar biophysical environment ( AX lung-on-chip). The latter mimics key features of the in vivo alveolar milieu: breathing-like 3D cyclic stretch (10% linear strain, 0.2 Hz frequency) and an ultrathin, porous and elastic membrane. AX iAECs cultured on-chip were characterized for their alveolar epithelial cell markers by gene and protein expression. Cell barrier properties were examined by TER (Transbarrier Electrical Resistance) measurement and tight junction formation. To establish a physiological model for the distal lung, AX iAECs were cultured for long-term at air-liquid interface (ALI) on-chip. To this end, different stages of alveolar damage including inflammation (via exposure to bacterial lipopolysaccharide) and the response to a profibrotic mediator (via exposure to Transforming growth factor β1) were analyzed. In addition, the expression of relevant host cell factors involved in SARS-CoV-2 infection was investigated to evaluate its potential application for COVID-19 studies. This study shows that AX iAECs cultured on the AX lung-on-chip exhibit an enhanced in vivo-like alveolar character which is reflected into: 1) Alveolar type 1 (AT1) and 2 (AT2) cell specific phenotypes, 2) tight barrier formation (with TER above 1,000 Ω cm 2 ) and 3) reproducible long-term preservation of alveolar characteristics in nearly physiological conditions (co-culture, breathing, ALI). To the best of our knowledge, this is the first time that a primary derived alveolar epithelial cell line on-chip representing both AT1 and AT2 characteristics is reported. This distal lung model thereby represents a valuable in vitro tool to study inhalation toxicity, test safety and efficacy of drug compounds and characterization of xenobiotics.

On the path to predicting immune responses in the lung: Modeling the pulmonary innate immune system at the air-liquid interface (ALI)

A storm in a teacup -- A biomimetic lung microphysiological system in conjunction with a deep-learning algorithm to monitor lung pathological and inflammatory reactions

Innate Immunity of the Lung: From Basic Mechanisms to Translational Medicine

Modeling of lung-liver interaction during infection in a human microfluidic organ-on-a-chip

A New Immortalized Human Alveolar Epithelial Cell Model to Study Lung Injury and Toxicity on a Breathing Lung-On-Chip System

Blood myeloid cells differentiate to lung resident cells and respond to pathogen stimuli in a 3D human tissue-engineered lung model

3D tissue-engineered lung models to study immune responses following viral infections of the small airways

The breathtaking world of human respiratory in vitro models: Investigating lung diseases and infections in 3D models, organoids, and lung‐on‐chip

Towards an artificial human lung: modelling organ-like complexity to aid mechanistic understanding

Potential pharmaceuticals targeting neuroimmune interactions in treating acute lung injury

Capturing the Onset of Bacterial Pulmonary Infection in Acini-On-Chips

Organoids As a Powerful Model for Respiratory Diseases

Building a human lung from pluripotent stem cells to model respiratory viral infections

Advanced lung organoids for respiratory system and pulmonary disease modeling

Integration of bioprinting advances and biomechanical strategies for in vitro lung modelling

Human lung organoid: Models for respiratory biology and diseases

Alveolar macrophages in tissue homeostasis, inflammation, and infection: evolving concepts of therapeutic targeting

Airway-On-A-Chip: Designs and Applications for Lung Repair and Disease

Lung viral infection modelling in a bioengineered whole-organ

Cytokine-Ion Channel Interactions in Pulmonary Inflammation

Recent advances in lung-on-a-chip technology for modeling respiratory disease